Currently, the major treatment approaches for HNSCC remains surgery, radiotherapy, chemotherapy, and EGFR-specific antibodies (e.g., chemoradiotherapy or concomitant with cetuximab) [57,58]. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.